Provided for information of learned professionals:

The proprietary and patented capric acid formulation in Doxall™ products has been successfully tested against the following pathogens:

Viruses

  • Herpes simplex virus-1
  • Herpes simplex virus-2
  • SARS-CoV-1 (SARS)
  • Murine hepatitis virus-1 (COVID-19 TGA surrogate)
  • Ebola
  • Influenza
  • Rhinovirus
US Centre for Disease Control Biggest Threats List (Bacteria)
  • Methicillin-resistant Staphylococcus aureus (MRSA) Streptococcus pneumoniae
  • C. difficile (vegetative cells and spores)
  • Carbapenem-resistant Enterobacteriaceae (CRE)
  • Acinetobacter baumannii
  • Extended spectrum beta-lactamase producing Enterobacteriaceae (ESBLs)
  • Multidrug-resistant Pseudomonas aeruginosa

        Other bacteria

        • E. Coli
        • Staphylococcus aureus
        • Streptococcus pyogenes
        • E. coli (including MCR-1 positive)
        • Klebsiella pneumoniae
        • Proteus vulgaris

                  Biowarfare agents

                  • Anthrax (B. atrophaeus* and B. anthracis (Sterne))
                  • Botulism (C. butyricum)
                  • Pseudomallei (B. thailandensis)

                      Fungi

                      • Candida auris
                      • Candida albicans